MOH Add to watchlist $146.88 0.63 (-0.43%) Last updated: Apr 16, 2026 01:01
52-Week Range
$146.88
$121.06 $146.88 $340.88

Fundamentals Overview

Molina Healthcare, Inc. is near the low of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 15.8 P/B 1.83 P/S 0.17

Intrinsic value (DCF)

+642.1% upside vs price

Profitability

Net margin 1%

Risk (Beta)

0.55 — lower vol

Earnings & growth

EPS $9.29 Rev -0.9% Profit -302.5% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 56% confidence Risk: Lower Volatility — Beta 0.55. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +642.1% upside vs price · Analyst grade: A-

Pressures (Sell):

Sentiment weakening (4 downgrades) · 3M vs S&P 500: -19.9% · 3M vs Healthcare sector: -13.2%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$7.65B
P/E (TTM)
15.81
EPS (TTM)
$9.29
Dividend Yield
N/A
52-Week Range
$121.06 - $340.88
Volume vs Avg
N/A
Beta
0.55

About

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is head...
Sector: Healthcare
Headquarters: US
Employees: 18,000
IPO Date: Jul 2003
Beta: 0.55 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 1, Equal Weight: 5, Hold: 3, Neutral: 11, Outperform: 2, Overweight: 5, Underweight: 3.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $1,090.05; current price is $146.88. That’s a +642.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 15.81
DCF value (model) $1,090.05 (642.1% upside)
PEG (TTM) N/A
P/B (TTM) 1.83
P/S (TTM) 0.17
Liquidity & enterprise
Current Ratio (TTM) 1.69
Quick Ratio (TTM) 1.69
Cash Ratio (TTM) 0.58
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 1.04%
Gross margin (TTM) 8.97%
Operating margin (TTM) 1.72%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for MOH.

Analyst Sentiment at a Glance

A- Sentiment Weakening
Buy 1Equal Weight 5Hold 3Neutral 11Outperform 2Overweight 5Underweight 3
0 upgrades, 4 downgrades
Price Target Consensus
Current $146.88
Median $158.00
Consensus $175.64
Low consensus $124.00
High consensus $310.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Mizuho maintain Outperform Outperform 2026-03-12
UBS maintain Neutral Neutral 2026-03-12
Morgan Stanley maintain Equal Weight Equal Weight 2026-03-04
Wells Fargo downgrade Overweight Equal Weight 2026-02-20
Truist Securities maintain Hold Hold 2026-02-17
Goldman Sachs maintain Neutral Neutral 2026-02-12
Barclays maintain Underweight Underweight 2026-02-10
TD Cowen maintain Hold Hold 2026-02-09
Cantor Fitzgerald maintain Neutral Neutral 2026-02-09
Wells Fargo maintain Overweight Overweight 2026-01-07
Barclays maintain Underweight Underweight 2026-01-05
Wells Fargo maintain Overweight Overweight 2025-11-12
Goldman Sachs maintain Neutral Neutral 2025-10-24
Cantor Fitzgerald maintain Neutral Neutral 2025-10-24
Barclays downgrade Equal Weight Underweight 2025-10-24
UBS maintain Neutral Neutral 2025-10-24
Morgan Stanley maintain Equal Weight Equal Weight 2025-10-14
Wells Fargo maintain Overweight Overweight 2025-10-07
Bernstein maintain Outperform Outperform 2025-09-05
Barclays maintain Equal Weight Equal Weight 2025-09-04
Cantor Fitzgerald maintain Neutral Neutral 2025-08-26
Wells Fargo maintain Overweight Overweight 2025-08-15
JP Morgan maintain Neutral Neutral 2025-07-29
Baird maintain Neutral Neutral 2025-07-25
Truist Securities downgrade Buy Hold 2025-07-25
UBS maintain Neutral Neutral 2025-07-25
Barclays maintain Equal Weight Equal Weight 2025-07-25
Cantor Fitzgerald downgrade Overweight Neutral 2025-07-25
Wells Fargo maintain Overweight Overweight 2025-07-23
Truist Securities maintain Buy Buy 2025-07-16